GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Zymergen Inc (NAS:ZY) » Definitions » Forward PE Ratio

Zymergen (Zymergen) Forward PE Ratio : 0.00 (As of May. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Zymergen Forward PE Ratio?

Zymergen's Forward PE Ratio for today is 0.00.

Zymergen's PE Ratio without NRI for today is 0.00.

Zymergen's PE Ratio for today is 0.00.


Zymergen Forward PE Ratio Historical Data

The historical data trend for Zymergen's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zymergen Forward PE Ratio Chart

Zymergen Annual Data
Trend
Forward PE Ratio

Zymergen Quarterly Data
Forward PE Ratio

Competitive Comparison of Zymergen's Forward PE Ratio

For the Specialty Chemicals subindustry, Zymergen's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zymergen's Forward PE Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Zymergen's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Zymergen's Forward PE Ratio falls into.



Zymergen Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Zymergen  (NAS:ZY) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Zymergen Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Zymergen's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zymergen (Zymergen) Business Description

Traded in Other Exchanges
N/A
Address
5980 Horton Street, Suite 105, Emeryville, CA, USA, 94608
Zymergen Inc is a biofacturing company. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries. A unique combination of biology, chemistry, software and automation enables the company to design and create new materials.
Executives
Enakshi Singh officer: Chief Financial Officer 5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Mina Kim officer: Chief Legal Officer C/O ACELYRIN, INC., 4149 LIBERTY CANYON RD., AGOURA HILLS CA 91301
Zachariah Serber director, officer: Chief Science Officer 5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Aaron Kimball officer: Chief Technology Officer 5980 HORTON ST., STE 105 EMERYVILLE CA 94025
Jay T Flatley director 9885 TOWNE CENTRE DR, SAN DIEGO CA 92121
Svf Excaliber (cayman) Ltd 10 percent owner 27 HOSPITAL ROAD, WALKERS CORPORATE LTD., CAYMAN CORPORATE CENTRE, GEORGE TOWN, GRAND CAYMAN E9 KY-9008
Josh Hoffman director, officer: Chief Executive Officer 5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Erik Jedidiah Dean officer: VP Operations and Engineering 5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Rohit Sharma director 575 HIGH STREET PALO ALTO CA 94301
Travis Murdoch director 1 CIRCLE STAR WAY SAN CARLOS CA 94070
Matthew Ocko director 270 UNIVERSITY AVENUE, PALO ALTO CA 94301
Svf Endurance (cayman) Ltd 10 percent owner C/O WALKERS CORPORATE LIMITED, 27 HOSPITAL ROAD, GEORGE TOWN E9 KY1-9008
Softbank Vision Fund (aiv M1) L.p. 10 percent owner 251 LITTLE FALLS DRIVE, WILMINGTON DE 19808
Sb Investment Advisers (uk) Ltd 10 percent owner 69 GROSVENOR STREET, LONDON X0 W1K 3JP
Christine Marie Gorjanc director 4500 GREAT AMERICA PARKWAY, SANTA CLARA CA 95054

Zymergen (Zymergen) Headlines

From GuruFocus

Zymergen Reports Preliminary First Quarter 2022 Financial Results

By GuruFocusNews GuruFocusNews 07-01-2022

Zymergen Reports Preliminary First Quarter 2022 Financial Results

By GuruFocusNews GuruFocusNews 06-21-2022

Zymergen Reports Preliminary First Quarter 2022 Financial Results

By GuruFocusNews GuruFocusNews 06-01-2022